The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
The MPN package computes the Most Probable Number (i.e. microbial density) and other microbial enumeration metrics derived from serial dilutions.
mpn()
MPN includes the mpn()
function to
estimate the Most Probable Number (MPN), its variance and
confidence interval, and Blodgett’s (2, 3, 4) Rarity Index
(RI).
The user inputs the number of dilutions, number of tubes, number of positive tubes, amount of inocula, confidence level, and confidence interval method.
As discussed in the references, MPN is estimated by maximizing likelihood. Combining the notaton of Blodgett (2) and Jarvis et al. (7), we write the likelihood function as:
\[L = L(\lambda; x_i, n_i, z_i, i = 1,...,k) = \prod_{i=1}^k \binom{n_i}{x_i} {(1-exp(-{\lambda}{z_i}))} ^ {x_i} {(exp(-{\lambda}{z_i}))} ^ {n_i-x_i}\]
where
As an R function:
#likelihood
L <- function(lambda, positive, tubes, amount) {
binom_coef <- choose(tubes, positive)
exp_term <- exp(-lambda * amount)
prod(binom_coef * ((1 - exp_term) ^ positive) * exp_term ^ (tubes - positive))
}
L_vec <- Vectorize(L, "lambda")
As is typical of maximum likelihood approaches, mpn()
uses the score function (derivative of the log-likelihood) to solve for
\(\hat{\lambda}\), the maximum
likelihood estimate (MLE) of \(\lambda\) (i.e., the point estimate of
MPN). However, let’s demonstrate what is happening in terms of
the likelihood function itself. Assume we have 10g of undiluted inoculum
in each of 3 tubes. Now we use a 10-fold dilution twice (i.e., the
relative dilution levels are 1, .1, .01). Also assume that exactly 1 of
the 3 tubes is positive at each dilution level:
#MPN calculation
library(MPN)
my_positive <- c(1, 1, 1) #xi
my_tubes <- c(3, 3, 3) #ni
my_amount <- 10 * c(1, .1, .01) #zi
(my_mpn <- mpn(my_positive, my_tubes, my_amount))
#> $MPN
#> [1] 0.1118255
#>
#> $MPN_adj
#> [1] 0.08725827
#>
#> $variance
#> [1] 0.00431064
#>
#> $var_log
#> [1] 0.3447151
#>
#> $conf_level
#> [1] 0.95
#>
#> $CI_method
#> [1] "Jarvis"
#>
#> $LB
#> [1] 0.03538176
#>
#> $UB
#> [1] 0.3534288
#>
#> $RI
#> [1] 0.005814327
If we plot the likelihood function, we see that \(\hat{\lambda}\) maximizes the likelihood:
my_mpn$MPN
#> [1] 0.1118255
lambda <- seq(0, 0.5, by = .001)
my_L <- L_vec(lambda, my_positive, my_tubes, my_amount)
plot(lambda, my_L, type = "l", ylab = "Likelihood", main = "Maximum Likelihood")
abline(v = my_mpn$MPN, lty = 2, col = "red")
If none of the tubes are positive, the MLE is zero:
no_positive <- c(0, 0, 0) #xi
(mpn_no_pos <- mpn(no_positive, my_tubes, my_amount)$MPN)
#> [1] 0
L_no_pos <- L_vec(lambda, no_positive, my_tubes, my_amount)
plot(lambda, L_no_pos, type = "l", xlim = c(-0.02, 0.2), ylab = "Likelihood",
main = "No Positives")
abline(v = mpn_no_pos, lty = 2, col = "red")
If all of the tubes are positive, then no finite MLE exists:
all_positive <- c(3, 3, 3) #xi
mpn(my_tubes, all_positive, my_amount)$MPN
#> [1] Inf
lambda <- seq(0, 200, by = .1)
L_all_pos <- L_vec(lambda, all_positive, my_tubes, my_amount)
plot(lambda, L_all_pos, type = "l", xlim = c(0, 100), ylim = c(0, 1.1),
ylab = "Likelihood", main = "All Positives")
abline(h = 1, lty = 2)
From a practical perspective, if all the tubes are positive, then the scientist should probably further dilute the sample until some tubes are negative.
mpn()
also returns a bias-adjusted version (9, 5,
6) of the point estimate:
As discussed in the references, many different confidence intervals
(CIs) can be calculated for the Most Probable Number. Currently,
mpn()
computes a CI using the approach of Jarvis et
al. (7) or the likelihood ratio approach of Ridout
(8). However, since these approaches rely on large-sample
theory, the results are more reliable for larger experiments.
my_positive <- c(1, 1, 1)
my_tubes <- c(3, 3, 3)
my_amount <- 10 * c(1, .1, .01)
mpn(my_positive, my_tubes, my_amount) #Jarvis approach
#> $MPN
#> [1] 0.1118255
#>
#> $MPN_adj
#> [1] 0.08725827
#>
#> $variance
#> [1] 0.00431064
#>
#> $var_log
#> [1] 0.3447151
#>
#> $conf_level
#> [1] 0.95
#>
#> $CI_method
#> [1] "Jarvis"
#>
#> $LB
#> [1] 0.03538176
#>
#> $UB
#> [1] 0.3534288
#>
#> $RI
#> [1] 0.005814327
mpn(my_positive, my_tubes, my_amount, CI_method = "LR") #likelihood ratio
#> $MPN
#> [1] 0.1118255
#>
#> $MPN_adj
#> [1] 0.08725827
#>
#> $variance
#> [1] NA
#>
#> $var_log
#> [1] NA
#>
#> $conf_level
#> [1] 0.95
#>
#> $CI_method
#> [1] "LR"
#>
#> $LB
#> [1] 0.02745596
#>
#> $UB
#> [1] 0.2975111
#>
#> $RI
#> [1] 0.005814327
As Jarvis (7) explains, Blodgett’s (2, 3, 4) Rarity Index is a ratio of two likelihoods. The likelihood in the numerator is for the actual results (i.e., evaluated at the MPN point estimate). The likelihood in the denominator is for the (hypothetical) results that would have given the largest possible likelihood. So RI is larger than 0 and at most 1. Values of RI that are very small are unlikely; therefore, the results should be regarded with suspicion.
The MPN package is more versatile than static Most Probable Number tables in that the number of tubes can vary across dilution levels, the user can choose any number (or levels) of dilutions, and the confidence level can be changed. Also, the Rarity Index, which quantifies the validity of the results, is included.
Bacteriological Analytical Manual, 8th Edition, Appendix 2, https://www.fda.gov/food/laboratory-methods-food/bam-appendix-2-most-probable-number-serial-dilutions
Blodgett RJ (2002). “Measuring improbability of outcomes from a serial dilution test.” Communications in Statistics: Theory and Methods, 31(12), 2209-2223.
Blodgett RJ (2005). “Serial dilution with a confirmation step.” Food Microbiology, 22(6), 547-552.
Blodgett RJ (2010). “Does a serial dilution experiment’s model agree with its outcome?” Model Assisted Statistics and Applications, 5(3), 209-215.
Haas CN (1989). “Estimation of microbial densities from dilution count experiments” Applied and Environmental Microbiology 55(8), 1934-1942.
Haas CN, Rose JB, Gerba CP (2014). “Quantitative microbial risk assessment, Second Ed.” John Wiley & Sons, Inc., ISBN 978-1-118-14529-6.
Jarvis B, Wilrich C, Wilrich P-T (2010). “Reconsideration of the derivation of Most Probable Numbers, their standard deviations, confidence bounds and rarity values.” Journal of Applied Microbiology, 109, 1660-1667.
Ridout MS (1994). “A Comparison of Confidence Interval Methods for Dilution Series Experiments.” Biometrics, 50(1), 289-296.
Salama IA, Koch GG, Tolley DH (1978). “On the estimation of the most probable number in a serial dilution technique.” Communications in Statistics - Theory and Methods, 7(13), 1267-1281.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.